← All organizations

Bioniz Therapeutics

Bioniz Therapeutics

For profitWebsite ↗

Also known as: Bioniz Therapeutics | Bioniz Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Oct 31, 2018

Acquired by Equillium on Feb 16, 2022

Timeline

2000s

Jan 1, 2009
Bioniz Therapeutics— Founded

2020s

Feb 16, 2022
Equillium— Acquired By

Drugs by trial phase (2 distinct, 4 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

NCT03532958Lead sponsorPhase 2Oct 31, 2018
NCT03239392Study directorPhase 1/Phase 2Jan 23, 2018
NCT03239392Lead sponsorPhase 1/Phase 2Jan 23, 2018
NCT03239379Lead sponsorPhase 1Oct 30, 2017
NCT03239379Study directorPhase 1Oct 30, 2017
NCT03046459Lead sponsorPhase 1Nov 1, 2016
NCT03046459Study directorPhase 1Nov 1, 2016

Details

Founded: Irvine, CA, US Jan 1, 2009
Last known activity: Oct 31, 2018